Carbon helps develop low-cost, 3D-printed TB testing device for developing countries

Where you live should not determine whether you live or die, to quote Bono, lead singer of the rock band U2, but, sadly, it often does. I was reminded of Bono’s phrase as I was reading about the contribution that Silicon Valley–based 3D-printing technology company Carbon (Redwood City, CA) made to the development of a low-cost, easy-to-use in vitro diagnostic (IVD) device to test for tuberculosis (TB).

Carbon TB Cassette

Of the 10 million people that contract TB globally each year, more than 40% go undiagnosed or unreported, the vast majority of whom live in the developing world, according to the World Health Organization. To address this issue in countries with limited healthcare infrastructures, the Global Good Fund (Bellevue, WA) got to work. A collaboration between Intellectual Ventures (IV; Bellevue, WA), a private enterprise involved in the development and licensing of intellectual property, and Bill Gates, the Global Good Fund spearheaded the development of an easy-to-use, affordable early TB diagnostic device. Carbon brought its expertise to the project, which resulted in the manufacture of hundreds of these devices for use in field trials.

Read more

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.